Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec 6:2:101.
doi: 10.21037/tgh.2017.11.09. eCollection 2017.

Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for granted

Antonio Riccardo Buonomo  1 , Ivan Gentile  1 , Guglielmo Borgia  1
Affiliations
Editorial

Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for granted

Antonio Riccardo Buonomo et al. Transl Gastroenterol Hepatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: I Gentile acted as a consultant for AbbVie and MSD. He received a grant from Gilead Sciences (in the framework of Fellowship program). The other authors have no conflicts of interest to declare.

Comment on

References

    1. Gentile I, Maraolo AE, Buonomo AR, et al. The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C. Expert Opin Drug Discov 2015;10:1363-77. 10.1517/17460441.2015.1094051 - DOI - PubMed
    1. Gentile I, Borgia G. A pill a day keeps HCV away. Lancet Infect Dis 2015;15:616-7. 10.1016/S1473-3099(15)70127-1 - DOI - PubMed
    1. Younossi ZM, Singer ME, Mir HM, et al. Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients. J Hepatol 2014;60:530-7. 10.1016/j.jhep.2013.11.009 - DOI - PubMed
    1. Foster GR, Irving WL, Cheung MC, et al. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol 2016;64:1224-31. 10.1016/j.jhep.2016.01.029 - DOI - PubMed
    1. Cheung MC, Walker AJ, Hudson BE, et al. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol 2016;65:741-7. 10.1016/j.jhep.2016.06.019 - DOI - PubMed

LinkOut - more resources